KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Outstanding (2018 - 2025)

Adaptive Biotechnologies' Shares Outstanding history spans 8 years, with the latest figure at $153.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 4.06% year-over-year to $153.8 million; the TTM value through Dec 2025 reached $153.8 million, up 4.06%, while the annual FY2025 figure was $153.8 million, 4.06% up from the prior year.
  • Shares Outstanding for Q4 2025 was $153.8 million at Adaptive Biotechnologies, up from $152.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $153.8 million in Q4 2025 and bottomed at $139.9 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $144.7 million (2023), against an average of $145.7 million.
  • The largest annual shift saw Shares Outstanding grew 10.47% in 2021 before it increased 1.21% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $141.4 million in 2021, then grew by 1.21% to $143.1 million in 2022, then increased by 1.38% to $145.1 million in 2023, then rose by 1.86% to $147.8 million in 2024, then increased by 4.06% to $153.8 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Shares Outstanding are $153.8 million (Q4 2025), $152.6 million (Q3 2025), and $152.2 million (Q2 2025).